Translational Cardiovascular Research Seminar SeriesTranscatheter Mitral Valve Replacement Recent Posts Transcatheter Innovation: Highlights of New Valve Designs Tricuspid Interventions An Engineering Perspective on Contemporary Issues With TAVR Vancouver SCAD Conference
Read More
Journal Club - August 18, 2022RAFT-AF Trial Jason Gencher presented the RAFT-AF Trial which was a randomized, multicenter, open-label trial comparing ablation-based rhythm control to rate control among patients with high-burden paroxysmal (>4 episodes in 6 months)
Read More
Journal Club - June 16, 2022SODIUM-HF Trial Miles Marchand presented the SODIUM-HF Trial which was an international, open-label, randomised, controlled trial comparing usual care according to local guidelines or a low sodium diet of less than
Read More
Journal Club - May 5, 2022PACMAN-AMI Trial Majeed Alosail presented the PACMAN-AMI Trial which was a double-blind, placebo-controlled, randomized clinical trial comparing the use of biweekly subcutaneous alirocumab to placebo, in addition to high-intensity statin therapy among
Read More
Journal Club - April 14, 2022CHAP Trial Andy Dhaliwal presented the CHAP Trial which was an open-label, multicenter, randomized trial, comparing the use of antihypertensive medications to no treatment (unless severe hypertension developed) among pregnant women with mild chronic hypertension and
Read More
Translational Cardiovascular Research Seminar SeriesWhat can PET Add to Prosthetic Valve Assessment - Dr. Marc Dweck How is hemodynamics associated with valve durability? - Dr. Lars Sondergaard Recent Posts Transcatheter
Read More
Journal Club - March 24, 2022DISCHARGE Trial River Jiang presented the DISCHARGE Trial which is a pragmatic, randomized trial comparing CT with Invasive Coronary Angiography (ICA) as initial diagnostic imaging strategies for guiding the treatment
Read More
Journal Club - March 10, 2022PARADISE-MI Trial Andrew Kochan presented the PARADISE-MI Trial. The trial's goal was to assess the efficacy and safety of sacubitril/valsartan compared with ramipril in the acute myocardial infarction (AMI) population. This
Read More
Coronary Physiology in 2022Dr. Stephane Fournier, Lausanne University Center Hospital Recent Posts Transcatheter Innovation: Highlights of New Valve Designs Tricuspid Interventions An Engineering Perspective on Contemporary Issues With TAVR Vancouver
Read More
Journal Club - March 3, 2022APAF-CRT Mortality Trial Jason Gencher presented the APAF-CRT Mortality Trial which was an international, open-label, blinded outcome trial of patients with severely symptomatic permanent atrial fibrillation for greater than 6 months, a
Read More